Published in Genet Vaccines Ther on September 04, 2003
B cells expressing IL-10 mRNA modulate memory T cells after DNA-Hsp65 immunization. Braz J Med Biol Res (2015) 0.75
Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet (2003) 6.95
Barriers to nonviral gene delivery. J Pharm Sci (2003) 1.77
Gene therapy: designer promoters for tumour targeting. Trends Genet (2000) 1.16
Chitosan and its derivatives--a promising non-viral vector for gene transfection. J Control Release (2002) 1.13
The cost of a cure. US News World Rep (2003) 0.87
Gene therapy. Nurs Clin North Am (2000) 0.86
Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med (2004) 2.06
New perspectives on central and peripheral immune responses to acute traumatic brain injury. J Neuroinflammation (2012) 1.34
Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respir Res (2002) 1.30
Natriuretic peptide receptor a as a novel anticancer target. Cancer Res (2008) 1.14
2'-5' Oligoadenylate synthetase plays a critical role in interferon-gamma inhibition of respiratory syncytial virus infection of human epithelial cells. J Biol Chem (2002) 1.09
Lateral fluid percussion injury of the brain induces CCL20 inflammatory chemokine expression in rats. J Neuroinflammation (2011) 1.09
Prenatal depression and anxiety in Toxoplasma gondii-positive women. Am J Obstet Gynecol (2011) 1.08
Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. Hum Gene Ther (2002) 1.04
Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells. J Virol (2011) 1.02
Development of hyaluronic acid-Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides. Nanomedicine (2007) 1.01
ERK-1/2 activity is required for efficient RSV infection. FEBS Lett (2004) 1.01
Chitosan IFN-gamma-pDNA Nanoparticle (CIN) Therapy for Allergic Asthma. Genet Vaccines Ther (2003) 0.99
A 3D fibrous scaffold inducing tumoroids: a platform for anticancer drug development. PLoS One (2013) 0.97
Respiratory syncytial virus infection activates STAT signaling in human epithelial cells. Biochem Biophys Res Commun (2003) 0.96
Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor. Genet Vaccines Ther (2008) 0.92
Mucosal delivery of a double-stapled RSV peptide prevents nasopulmonary infection. J Clin Invest (2014) 0.92
Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharm Res (2006) 0.92
Adenovirus-mediated interferon gamma gene therapy for allergic asthma: involvement of interleukin 12 and STAT4 signaling. Hum Gene Ther (2002) 0.91
Natriuretic peptide receptor a as a novel target for prostate cancer. Mol Cancer (2011) 0.91
Nanoparticle-mediated gene delivery: state of the art. Expert Opin Biol Ther (2004) 0.90
Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery. Genet Vaccines Ther (2004) 0.89
Curcumin prevents human dendritic cell response to immune stimulants. Biochem Biophys Res Commun (2008) 0.88
Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice. Virol J (2006) 0.88
Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene. Genet Vaccines Ther (2007) 0.88
Enhancer of zeste homolog 2 induces pulmonary artery smooth muscle cell proliferation. PLoS One (2012) 0.88
Thiolated chitosan nanoparticles enhance anti-inflammatory effects of intranasally delivered theophylline. Respir Res (2006) 0.87
Ultrasensitive detection of cortisol with enzyme fragment complementation technology using functionalized nanowire. Biosens Bioelectron (2006) 0.86
An immunocompromised BALB/c mouse model for respiratory syncytial virus infection. Virol J (2005) 0.86
Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment. PLoS One (2013) 0.85
Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma. Respir Res (2009) 0.84
Protein kinase C-alpha activity is required for respiratory syncytial virus fusion to human bronchial epithelial cells. J Virol (2004) 0.84
Mechanism of bronchoprotective effects of a novel natriuretic hormone peptide. J Allergy Clin Immunol (2004) 0.83
Atrial natriuretic peptide gene transfer by means of intranasal administration attenuates airway reactivity in a mouse model of allergic sensitization. J Allergy Clin Immunol (2002) 0.82
Serum total IgE and specific IgE to Dermatophagoides pteronyssinus, but not eosinophil cationic protein, are more likely to be elevated in elderly asthmatic patients. Allergy Asthma Proc (2004) 0.82
Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity. Int Immunopharmacol (2003) 0.81
Chitosan Interferon-gamma Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses. Allergy Asthma Clin Immunol (2008) 0.80
Mite and cockroach proteases activate p44/p42 MAP kinases in human lung epithelial cells. Clin Mol Allergy (2003) 0.80
Natriuretic peptide receptor A signaling regulates stem cell recruitment and angiogenesis: a model to study linkage between inflammation and tumorigenesis. Stem Cells (2013) 0.79
Chitosan nanoparticle-mediated gene transfer. Methods Mol Biol (2008) 0.78
Respiratory syncytial virus: immunopathology and control. Expert Rev Clin Immunol (2006) 0.75
Modifying allergens and using adjuvants for specific immunotherapy. Clin Allergy Immunol (2004) 0.75
Nano/bio interface:impact on drug delivery applications. Drug Deliv Transl Res (2013) 0.75